{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "3295112",
  "DateCompleted": {
    "Year": "1987",
    "Month": "07",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "07",
    "Day": "24"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0022-3018",
      "JournalIssue": {
        "Volume": "175",
        "Issue": "6",
        "PubDate": {
          "Year": "1987",
          "Month": "Jun"
        }
      },
      "Title": "The Journal of nervous and mental disease",
      "ISOAbbreviation": "J Nerv Ment Dis"
    },
    "ArticleTitle": "Initial depression and response to imipramine in agoraphobia.",
    "Pagination": {
      "StartPage": "358",
      "EndPage": "361",
      "MedlinePgn": "358-61"
    },
    "Abstract": {
      "AbstractText": [
        "Thirty-seven patients participating in a controlled treatment study with imipramine were classified as high or low depressed simultaneously on two depression measures. Analysis of variance by 2 (high-low depressed) X 2 (high-low imipramine dosage) groupings revealed significant dose but no depression main effects. The greater dose effect observed in the low depressed group and the greater response rates found among high-dose patients with low initial depression strongly suggest that the beneficial effect of imipramine in agoraphobia was not primarily antidepressant in nature."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mavissakalian",
        "ForeName": "M",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "MH42730",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "MH49141",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Journal Article",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Nerv Ment Dis",
    "NlmUniqueID": "0375402",
    "ISSNLinking": "0022-3018"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "OGG85SX4E4",
      "NameOfSubstance": "Imipramine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "psychology"
      ],
      "DescriptorName": "Agoraphobia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "psychology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dose-Response Relationship, Drug"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Imipramine"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Phobic Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychiatric Status Rating Scales"
    }
  ]
}